FMP
May 23, 2024 6:00 AM - Alex Lavoie
PetMed Express, Inc., known by its NASDAQ:PETS, is gearing up to release its quarterly earnings on Monday, May 27, 2024, before the market opens. Wall Street's expectations are set at an earnings per share (EPS) of $0.06, with projected revenue for the quarter around $65 million. This announcement is particularly significant for investors and analysts who closely monitor the company's financial health and performance. PetMed Express, operating in the competitive online pet pharmacy sector, faces stiff competition from both online and brick-and-mortar retailers offering pet medications and health products.
Following the earnings release, PetMed Express has scheduled a conference call on June 11, 2024, to discuss its financial results for the fourth quarter and the full fiscal year ending March 31, 2024. This call will allow management to provide insights into the company's performance and strategic direction. Interested parties can join the call through specified U.S. and international numbers or follow a webcast, with a replay available post-call until June 25, 2024. This direct communication with PetMed Express's management team offers a valuable opportunity for investors to gauge the company's future prospects.
PetMed Express's financial metrics reveal a complex picture. Despite a negative price-to-earnings (P/E) ratio of -10.41, indicating current unprofitability, other ratios suggest the stock might be undervalued. The price-to-sales (P/S) ratio at 0.31 and the enterprise value-to-sales (EV/Sales) ratio at 0.14 point towards potential undervaluation based on sales revenue. Furthermore, the enterprise value to operating cash flow (EV/OCF) ratio stands at 5.69, highlighting the company's ability to generate cash relative to its enterprise value.
However, the earnings yield is negative at -9.61%, reflecting the company's challenges in achieving profitability. On a more positive note, the debt-to-equity (D/E) ratio is very low at 0.016, indicating minimal debt usage, which is a good sign for financial stability. The current ratio of 1.32 also suggests that PetMed Express is well-positioned to meet its short-term liabilities with its current assets. These financial indicators will be crucial for investors to consider as they assess PetMed Express's earnings report and future potential in the competitive pet medication market.
Jan 16, 2024 4:18 PM - Samuel Abdelshahid
In the hustle and bustle of the trading world, having a trustworthy laptop is like having a reliable partner by your side. Making well-informed decisions and staying ahead of market trends become second nature with the right device. However, the quest for a budget-friendly trading laptop t...
Jan 21, 2024 4:00 AM - Parth Sanghvi
Introduction: In the world of financial analysis, a profound grasp of essential profitability metrics is vital. This blog delves into three pivotal metrics—ROE (Return on Equity), ROA (Return on Assets), and Net Profit Margin—offering clear insights without unnecessary complexity. Exploring RO...
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...